These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31495903)

  • 21. Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.
    Xie F; Ye L; Chang JC; Beyer AI; Wang J; Muench MO; Kan YW
    Genome Res; 2014 Sep; 24(9):1526-33. PubMed ID: 25096406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.
    Yan JM; Li DZ
    Hemoglobin; 2017 May; 41(3):198-202. PubMed ID: 28835139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.
    Tang ZH; Chen JR; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Huang TS; Chen P; Guan MX; Wang JF
    Stem Cells Transl Med; 2016 May; 5(5):561-71. PubMed ID: 27013738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9 system and its applications in human hematopoietic cells.
    Hu X
    Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal Degeneration.
    Burnight ER; Gupta M; Wiley LA; Anfinson KR; Tran A; Triboulet R; Hoffmann JM; Klaahsen DL; Andorf JL; Jiao C; Sohn EH; Adur MK; Ross JW; Mullins RF; Daley GQ; Schlaeger TM; Stone EM; Tucker BA
    Mol Ther; 2017 Sep; 25(9):1999-2013. PubMed ID: 28619647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematological Characteristics of Hb Constant Spring (
    Jiang F; Xu LL; Chen GL; Zhou JY; Li J; Tang XW; Zuo LD; Li DZ
    Hemoglobin; 2020 Mar; 44(2):86-88. PubMed ID: 32338097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells.
    He L; Wang S; Peng L; Zhao H; Li S; Han X; Habimana JD; Chen Z; Wang C; Peng Y; Peng H; Xie Y; Lei L; Deng Q; Wan L; Wan N; Yuan H; Gong Y; Zou G; Li Z; Tang B; Jiang H
    Transl Psychiatry; 2021 Sep; 11(1):479. PubMed ID: 34535635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalassemia intermedia in HbH-CS disease with compound heterozygosity for beta-thalassemia: challenges in hemoglobin analysis and clinical diagnosis.
    Tan JA; Kok JL; Tan KL; Wee YC; George E
    Genes Genet Syst; 2009 Feb; 84(1):67-71. PubMed ID: 19420802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
    Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
    Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on gene mutations of alpha-thalassemia in the South of China].
    Duan S; Li HY; Chen Z; Chen SQ; Bi XJ; Chen LM; Du CS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):54-60. PubMed ID: 12667291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient-Derived iPSCs.
    Li D; Ou M; Zhang W; Luo Q; Cai W; Mo C; Liang W; Dai G; Yin L; Zhu P; Tang D; Dai Y
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):131. PubMed ID: 37395026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
    Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
    Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CGMP Compliant Microfluidic Transfection of Induced Pluripotent Stem Cells for CRISPR-Mediated Genome Editing.
    Bohrer LR; Stone NE; Wright AT; Han S; Sicher I; Sulchek TA; Mullins RF; Tucker BA
    Stem Cells; 2023 Nov; 41(11):1037-1046. PubMed ID: 37632456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hb Koya Dora [alpha142, Term-->Ser (TAA>TCA in alpha2)]: a rare mutation of the alpha2 gene stop codon associated with alpha-thalassemia.
    Brennan SO; Ryken S; Chan T
    Hemoglobin; 2010; 34(4):402-5. PubMed ID: 20642339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hb Constant Spring [alpha 142, Term-->Gln (TAA>CAA in alpha2)] in the alpha-thalassemia of anemic patients in Myanmar.
    Ne-Win ; Harano K; Harano T; Kyaw-Shwe ; Aye-Aye-Myint ; Khin-Thander-Aye ; Okada S
    Hemoglobin; 2008; 32(5):454-61. PubMed ID: 18932070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
    Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
    Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of Hb Constant Spring [α142, Term→Gln, TAA>CAA (α2)] in heterozygotes combined with β-thalassemia.
    Li YQ; Li R; Li DZ
    Hemoglobin; 2013; 37(2):197-200. PubMed ID: 23390935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.